NEW DELHI: Drugmaker Novartis India could lay off round 170 individuals as a part of its workforce rationalization within the wake of Covid-19 impacting its enterprise in India, sources stated.
“The layoff plan has been drawn as a part of ‘match for future’ undertaking. The communication to recognized staff will likely be made by March 31,” a senior government advised TOI.
“Novartis is continually methods to finest meet our affected person’s wants with our progressive merchandise and pipeline whereas strengthening Novartis competitiveness. That is an ongoing course of as a part of which we consistently consider situations that allow us to make selections in accordance with each our enterprise wants and people of our sufferers and clients,” Novartis spokesperson stated in response to an in depth question.
The proposed growth assumes significance as this may in all probability be the primary job lower of this scale within the native pharma trade after the pandemic hit final yr. In addition to, the pharmaceutical trade is taken into account probably the most steady sector even in occasions of financial disaster.
In response to the senior government, the proposed downsizing presently entails solely the pharmaceutical section of Novartis and may be prolonged to different divisions going ahead.
Earlier this month, the Indian arm of the Swiss drug main reported a internet lack of Rs 71 lakh for the quarter ended December 31, 2020. The corporate had posted a internet revenue of Rs 7.73 crore for the corresponding interval of the earlier fiscal. Income from operations of the corporate stood at Rs 93.77 core for the quarter into account. It was Rs 117.46 crore for a similar interval a yr in the past.
